Thanks, Pete. I'll provide a brief overview and of course, welcome all of you to review our filings in greater detail or reach out to our team with any questions you may have. During the quarter ended June 30th, 2021, we reported consolidated revenue of 16.3 million, a net loss from continuing operations of 1.4 million, and adjusted EBITDA of 3.5 million. For the same period last year, we reported consolidated revenue of 14.7 million, net income from continuing operations of 4.1 million, and adjusted EBITDA of 5.9 million. These amounts do not include the contributions of our real estate business, which was sold on June 23, 2021 and previously reported financial information has been recast to reflect the real estate business as discontinued operations. As a result, we no longer report real estate as a separate segment of continuing operations. Great Elm reports the results of each of our two operating segments, including durable medical equipment and investment management, as well as unallocated general corporate activity. We'll begin the review with durable medical equipment. For the fiscal fourth quarter, DME generated 15.4 million in revenue compared to 13.9 million last year. The increase in revenues was due to organic growth in resupply sales and contributions from AM - PM add-on acquisition. The demand for sleep studies was soft due to the ongoing impacts from COVID-19 pandemic. And referrals for new equipment setups remain depressed as they are generally driven by in-house or external sleep studies. Although there are positive signs of recovering demand for sleep studies and for equipment setups heading into our next fiscal year, late in the fiscal fourth quarter, Philips Respironics announced a voluntary recall of certain C-PAP and ventilator products. Our DME business has sufficient on hand inventory stores in C-PAP and ventilator equipment to meet demand in the near term. However, the magnitude and duration of the current supply chain issues are unknown at this time. We continue to work closely with our suppliers while we navigate these industry challenges. That being said, we remain opportunistic on the acquisition front as the industry continues to consolidate. For the year ended June 30th, 2021, Great Elm DME s operations recognized a 3.6% increase in total revenue, increasing to 57.6 million compared to 55.7 million in the prior year. The increase in total revenue was due primarily to the AMF PM acquisition and organic growth in resupply sales. Great Elm DME 's operations reported net income of 5.9 million in comparison to 2.8 million in the prior period. Net income increased largely due to a $5.5 million benefit related to a fair value adjustment on an embedded derivative that was bifurcated from our Series A2 preferred stock. This preferred stock was issued to Forest Investments, Inc, our majority owned subsidiary and therefore, the income recognized on this adjustment has an offsetting charge to general corporate and eliminate some consolidation. Also contributing to net income was 2.4 million of stimulus in the form of refundable employee retention payroll tax credits that were claimed during our fiscal fourth quarter, 2021. This compares to 5.1 million of CARES Act stimulus received in the comparable prior year period. GME reported a net loss of 2.5 million for the year ended June 30th, 2021, compared to a net loss of 0.1 million in the prior year. In the current year, we recorded a non-recurring charge of 1.9 million related to the extinguishment of DME 's term loan in December, which lowered its cost of capital and provided DME with additional capital for acquisition opportunities. Also impacting this comparison is 4.6 million of employee retention credits recognized in fiscal 2021 versus 5.1 million in Cares Act stimulus recognized for the fiscal year 2020. Adjusted EBITDA, a non-GAAP measure was 4.3 million in the fiscal 2021, fourth quarter compared to 7.0 million in the prior period. Adjusted EBITDA was 12.4 million for the year ended June 30th, 2021, compared to 16.0 million in the prior year. Next, turning to investment management. For the fiscal fourth quarter, Investment Management generated 0.9 million in revenue compared to 0.7 million during the same period in the prior year. Revenue was slightly higher due to increases in the average assets on which such fees are calculated. Great Elm 's investment management business recognized 3.2 million in revenue for the year ended June 30th, 2021, compared to 3.3 million in the prior year. Investment Management reported net income of 1.3 million in comparison to 3.4 million in the prior year period. The increase was primarily due to an unrealized gain on managed investments of 1.0 million as compared to a gain of 2.9 million in the comparable quarter of the prior year. For the year, investment management recognized net income of 2.7 million as compared to a net loss of 6.2 million in fiscal 2020. The improvement is primarily related to 0.7 million in unrealized gains on managed investments in the current year versus 8.7 million in unrealized losses in fiscal year 2020. Before discussing the EBITDA, I wanted to highlight that beginning with the current quarter, we have made certain changes to segment presentation as it relates to the activity of our managed investments. Primarily our investment in GECC and in G SaaS. Non-operating activity related to these managed investments, including dividend income and unrealized gains, losses, are now presented as investment management activity, whereas previously they were presented within general corporate. We believe this presentation provides a better view into the performance of the segment. As such, previously reported financial information has been reclassified to conform to this presentation. Adjusted EBITDA was 100,000 in fiscal 2021 fourth quarter, compared to 200,000 during the same period in the prior year. Adjusted EBITDA was impacted in the current quarter, primarily by increased professional fees and employee-related costs related to growth initiatives. Adjusted EBITDA was 400,000 for the year ended June 30th, 2021, compared to 1.2 million during the prior year. Again, driven by cost related growth initiatives. Moving on to our general corporate segment. For the fiscal fourth quarter, Great Elm 's general corporate segment recognized 0.3 million in revenue compared to $45,000 in revenue during the same period in the prior year. In the year ended June 30, 2021, the general corporate segment recognized 0.6 million in revenue compared to 0.2 million in the prior year. Revenue increased as a result of increased management fees earned from DME, along with management fees earned from Forest under a new management agreement put into place in connection with the JPMorgan transactions in December of 2020. For the quarter, general corporate reported a net loss of 8.6 million as compared to a net loss of 2.1 million for our fourth fiscal quarter last year. This comparison is primarily impacted by the embedded derivative charge of 5.5 million in the current quarter. For the year, the general corporate had a net loss of 9.6 million in fiscal 2021 versus a net loss of 7.1 million in fiscal 2020. Activity impacting this comparison includes 700,000 of year-to-date embedded derivative net charges, as well as 1.8 million in income tax expense in 2021 versus $44,000 of income tax expense in the prior year. The current year tax provision is a result of the reorganization activities of certain subsidiaries in the current year. General corporate adjusted EBITDA for the current quarter was -0.9 million compared to -1.2 million in the comparable quarter last year. General corporate adjusted EBITDA for the current year was -4.2 million, compared to -6.0 million in fiscal year 2020. The improvement comes as a result of significant progress on reducing corporate overhead and is driven by lower audit and other professional fees related to active vendor management and other efficiencies. Turning to our consolidated financial position at quarter end. During fiscal 2021, we made significant strides in simplifying our corporate structure and reducing our leverage. Our aggregate borrowings, including debt, convertible notes, and redeemable preferred stock decreased by approximately $47 million, while our networking capital improved by $24 million, as compared to the prior year. These improvements, combined with an undrawn line of credit at DME and $24 million in cash on hand, put us in an excellent position to execute on our strategies in fiscal 2022. This concludes my financial review of the quarter, and I will turn it back to Pete for closing remarks.